Type 2 Diabetes
Type 2 Diabetes (T2D) is a chronic condition that affects the way your body metabolizes sugar (glucose), leading to high blood sugar levels. It often results in symptoms such as increased thirst, frequent urination, and fatigue.
Type 2 Diabetes: LY3457263 Treatment Study
We are testing a new medication, LY3457263, in people with type 2 diabetes who are not meeting their blood sugar goals on current treatments. The study will compare its effects to a placebo over 24 weeks.
11-15 visitsEfficacy phase (II)Partially RemoteInvestigational MedicinesInjectionEndocrinologyInternal Medicine
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Do you have type 2 diabetes?
- Are you overweight or obese?
- Have you had a stable body weight for the last three months?
- Are you currently taking injectable semaglutide or injectable tirzepatide?
- Have you taken any medications or remedies for weight loss in the last three months?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Nisotirotide
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
InnoDiab Forschung GmbH
Essen, Germany
Velocity Clinical Research Leipzig
Leipzig, Germany
Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut
Markkleeberg, Germany
Sponsor: Eli Lilly & Co.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.